Literature DB >> 12780767

Selective decrease in serotonin synthesis rate in rat brainstem raphe nuclei following chronic administration of low doses of amitriptyline: an effect compatible with an anti-migraine effect.

T Pringsheim1, M Diksic, C Dobson, K Nguyen, E Hamel.   

Abstract

The effects of chronic, low-dose amitriptyline on serotonin (5-HT) synthesis rate were measured in rat brain using autoradiography and the trapping of alpha-[14C]-methyl-L-tryptophan (alpha-[14C]-MTrp). Rats received amitriptyline (2 mg/kg per day) or saline via intraperitoneal osmotic minipumps for 21 days. Amitriptyline had no effect on any physiological parameters measured, or on free or total plasma tryptophan levels. However, amitriptyline exerted selective decreases of 15% and 17% (P < 0.001) in serotonin synthesis rates in the dorsal and median raphe nuclei, respectively. There was no reduction in any of the projection areas studied, including the cerebral cortex, hippocampus, thalamus, hypothalamus or striatum. The data suggest that chronic low doses of amitriptyline can lead to sustained 5-HT re-uptake inhibition selectively in the raphe nuclei, an effect compatible with tonic activation of 5-HT(1A) autoreceptors and inhibition of 5-HT synthesis. The failure of chronic amitriptyline treatment to affect 5-HT synthesis rate in the projection areas may ensure an adequate regulation of pain pathways implicated in migraine headache, an effect possibly related to amitriptyline anti-migraine efficacy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12780767     DOI: 10.1046/j.1468-2982.2003.00526.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  2 in total

1.  Depression and anxiety behaviour in a rat model of chronic migraine.

Authors:  Mingjie Zhang; Yufei Liu; Mangsuo Zhao; Wenjing Tang; Xiaolin Wang; Zhao Dong; Shengyuan Yu
Journal:  J Headache Pain       Date:  2017-02-21       Impact factor: 7.277

2.  Co-morbidities of interstitial cystitis.

Authors:  Gisela Chelimsky; Elizabeth Heller; C A Tony Buffington; Raymond Rackley; Di Zhang; Thomas Chelimsky
Journal:  Front Neurosci       Date:  2012-08-10       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.